Cargando…
Targeted Delivery of Plasminogen Activators for Thrombolytic Therapy: An Integrative Evaluation
In thrombolytic therapy, plasminogen activators (PAs) are still the only group of drug approved to induce thrombolysis, and therefore, critical for treatment of arterial thromboembolism, such as stroke, in the acute phase. Functionalized nanocomposites have attracted great attention in achieving tar...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766944/ https://www.ncbi.nlm.nih.gov/pubmed/31546842 http://dx.doi.org/10.3390/molecules24183407 |